Dr. Martens plc (LON:DOCS) Insider Purchases £151.24 in Stock

Dr. Martens plc (LON:DOCSGet Free Report) insider Kenny Wilson bought 199 shares of the business’s stock in a transaction on Wednesday, December 11th. The shares were acquired at an average price of GBX 76 ($0.96) per share, for a total transaction of £151.24 ($190.96).

Kenny Wilson also recently made the following trade(s):

  • On Thursday, September 26th, Kenny Wilson purchased 30,000 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 55 ($0.69) per share, with a total value of £16,500 ($20,833.33).

Dr. Martens Trading Down 0.6 %

Shares of LON DOCS opened at GBX 76.55 ($0.97) on Monday. The company’s 50 day simple moving average is GBX 59.81 and its 200 day simple moving average is GBX 67.25. The company has a debt-to-equity ratio of 129.55, a current ratio of 2.85 and a quick ratio of 1.13. Dr. Martens plc has a fifty-two week low of GBX 49.32 ($0.62) and a fifty-two week high of GBX 100 ($1.26). The firm has a market capitalization of £736.20 million, a P/E ratio of 1,093.57, a P/E/G ratio of 6.40 and a beta of 0.11.

Dr. Martens Cuts Dividend

The business also recently declared a dividend, which will be paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th will be given a GBX 0.85 ($0.01) dividend. The ex-dividend date of this dividend is Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens’s dividend payout ratio is currently 4,285.71%.

About Dr. Martens

(Get Free Report)

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Recommended Stories

Insider Buying and Selling by Quarter for Dr. Martens (LON:DOCS)

Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.